The medical gases market - France

The global medical gases market has grown significantly, with an average annual growth rate of 8.30%. This expansion is due to an aging population, increasing prevalence of chronic diseases and improved access to healthcare in developing countries, as well as favorable government initiatives. The COVID-19 pandemic also had a notable positive impact, boosting demand for medical gases, particularly oxygen, to treat patients.

In France, one of the main market players is Air Liquide Santé - France, with sales of €166.79 million in 2021. The French market reflects dynamic growth, with a substantial increase in spending on medical gases; for example, spending on CPAP treatment has risen to 862 million euros in 2021. Future challenges for the market include adapting to environmental concerns and integrating more sustainable practices, such as increasing on-site production and using less polluting alternatives like hydrogen. Regulations remain strict, with rigorous standards governing the packaging, distribution, transport and storage of medical gases to ensure safety.

Medical gas market trends and dynamics

The medical gases market in this country is undergoing a significant growth phase, fuelled by a variety of driving forces. These gases, essential in healthcare for the treatment and relief of pain, form part of the wider industrial gases sector, which finds application in a plethora of industries. If we look at recent trends, we see a growing demand due mainly to an ageing population, the rising prevalence of chronic diseases and improved access to healthcare in developing countries.

In addition, government initiatives and the recent unexpected surge in demand caused by the COVID-19 pandemic have also acted as catalysts. Key figures in the text indicate that the size of the global medical gases market is substantial, valued at between $14 and $15 billion in 2023. A robust average annual growth rate of around 8% is expected over the next decade, suggesting that market size could exceed $29 billion by the early 2030s.

More specifically, for the French market, a dynamic, upward trajectory is reflected in rising spending on medical gases. For example, treatments such as continuous positive airway pressure and oxygen therapy have accounted for expenditure in the range of 400 million euros to over 800 million euros. In addition, the market structure is described as being dominated by large international producers of industrial gases, implying a concentration of market power and high barriers to entry for new participants.

Air Liquide and other major players are driving the consolidation trend, and their international presence is being strengthened by strategic acquisitions, particularly in emerging markets, and by research and development initiatives. Regional data underline the trend, with medical gases for surgery and home healthcare showing solid growth. Growth patterns are linked to demographics, where a significant proportion of the population in the coming decades will be over 65, constituting a considerable potential consumer base for medical gases.

In France, the percentage of the population aged 75 and over is set to rise from a low single-digit percentage to a considerable double-digit figure by 2070. Medical gases themselves are diverse and vital, ranging from inhaled gases such as oxygen and nitrous oxide to other gases used in a variety of medical applications, including laparoscopy and laser therapy. Production dynamics are also important: despite a historic decline in some segments, recent years have seen a resurgence in industrial gas sales, suggesting a likely revitalization of domestic production capacities. Regulations govern the production, transport and use of medical gases, guaranteeing safety and proper labeling for handling. However, the market is challenged by the key players in the medical gases market who are shaping the healthcare landscape

The healthcare landscape

The medical gases market is a dynamic arena with a handful of dominant international players who have a significant influence on the industry's trajectory. Thanks to strategic acquisitions and a focus on innovation and diversification, these key players have consolidated their market position and continue to drive growth. Here's an overview of the main companies operating in this critical sector.

• Air Liquide: A pillar of the industry and world leader in gases, technologies and services for industry and healthcare, Air Liquide has a sub-segment, Air Liquide Santé, which caters specifically to the medical gases market. Air Liquide Santé - France is a subsidiary specialized in the manufacture of medical gases. It is known for its extensive network of sites across France, enabling it to distribute its products efficiently throughout the country. Its presence is not limited to France; it has a growing international footprint, guaranteeing a global supply chain to meet the growing demand for medical gases.
• Air Products & Chemicals: This American conglomerate is another heavyweight in the sector, distributing a wide range of industrial gases, including those for medical applications. Although the company itself supplies oxygen and other gases, its importance in the medical gases market is underlined by its association with Lida. Lida, also partly owned by other industry giants Linde and Messer, specializes in the production and packaging of medical gases and is establishing itself as an essential part of Air Products & Chemicals' service offering.
• Linde Healthcare: Offering a complete range of medical gases, Linde Healthcare France has established itself in the market by meeting the various needs of the healthcare sector, whether it is the need for the production of medical gases, or the need for the packaging of medical gases.s, from therapeutic and medical needs to the facilitation of gas-assisted procedures. Its expertise ranges from oxygen for inhalation therapy to nitrous oxide and medical air for anesthesia and aerosol therapy. Linde's focus on providing tailor-made solutions for different medical applications consolidates its market position.
• NOVAIR Medical: An innovative player in this field, NOVAIR Medical has made a name for itself by covering the entire value chain for medical gas systems. It not only produces medical gases, but also specializes in the distribution, monitoring, design and installation of medical gas systems. Its approach is to provide complete solutions that are not only efficient, but also prioritize ecological and economic considerations.

These organizations, with their diverse range of products and services, play an essential role in the dynamics of the medical gases market. They have adapted to contemporary challenges such as the rise in chronic diseases, an ageing population and public health problems

Informations

• Nombre de pages : 30 pages
• Format : Version digitale et PDF
• Dernière mise à jour : 17/11/2023

Sommaire et extraits

Liste des graphiques

• Taille du marché des gaz médicaux
• Montant remboursé sur les forfaits des secteurs concernés
• Projection de population à l'horizon 2070
• Proportion des 65 ans ou plus dans la population française
• Taille du marché français du gaz industriel
• Nombre de salariés et d'entreprises dans l'industrie du gaz industriel
• Montant prévu par la loi de la transition énergétique de la CCE (contribution climat-énergie) ou taxe carbone
• Évolution de l'indice de chiffre d'affaires de la production de gaz industriel
• Patients pris en charge par l'assistance médicale à domicile par type d'assistance
• Nombre de prises en charge d'embolie pulmonaire aiguë par tranche d'âge
• Population touchée par l'apnée du sommeil
• Chiffre d'affaires des prestataires santé à domicile